Background Little is known about the association between direct pollen exposure and cognitive performance. The aim of our ...

Objective: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical deci ...

This year, professor Charis Kubrin will get the biggest prize a criminologist can receive. She’s also under threat.

By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...

By Tarun Sai Lomte A large cross-sectional study of Japanese adults with type 2 diabetes reveals that alcohol intake may ...

Wondering where to find data for your Python data science projects? Find out why Kaggle is my go-to and how I explore data ...

Monday's five-game NHL slate pits some top playoff contenders against each other. Which teams are we betting will prevail in ...

Fantasy managers should think twice, as Houston Astros closer Josh Hader tops a list of high-profile relievers to avoid at ...

Patients on GLP-1s who stop taking the drugs may maintain 25% of their weight loss at one year, but whether their regained weight is mainly fat or lean mass isn’t clear.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Background Severe aortic stenosis (AS) is commonly associated with advanced cardiac damage, including right ventricular dysfunction (RVD), pulmonary hypertension (PH) and tricuspid regurgitation (TR), ...

Exploit timelines have collapsed and AI is compressing them further. A growing body of research suggests credit and loan ...